Blood cancers, Cell type, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at gemcitabine (Gemzar) and bexarotene (Targretin) for cutaneous T cell lymphoma that had come back or stopped responding to treatment. This trial was supported by Cancer Research UK.
Recruitment start: 26 March 2008
Recruitment end: 9 November 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Illidge
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
University College London (UCL)
This is Cancer Research UK trial number CRUK/07/016.
Last reviewed: 25 July 2013
CRUK internal database number: 711
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
